Concepedia
Statistics
Publications
15
Citations
1.8K
H-Index
14
Active since
2000
Affiliations
Amgen (United States)(Current)
University of Missouri–Kansas City
BioMarin (United States)
Pfizer (United States)
Gilead Sciences (United States)
Clapton Dias is an author at Amgen (United States) specializing in pharmacology, pharmacokinetics, and medicine.
Publications per year
2000–2019
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
Gail M. Gauvreau, Paul M. O’Byrne, Louis‐Philippe Boulet et al. · New England Journal of Medicine · 2014 · 780 citations · Full text
Life Sciences, Immunology, Pharmacology +14
Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels
Clapton Dias, Adam J. Shaywitz, Scott M. Wasserman et al. · Journal of the American College of Cardiology · 2012 · 234 citations
Life Sciences, Biochemistry, Nutritional Sciences +12
Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor<scp>X</scp>a inhibitor
Charles Frost, Wonkyung Byon, Yan Song et al. · British Journal of Clinical Pharmacology · 2014 · 158 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +16
Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis
Clapton Dias, Kenneth Todd Moore, Joe Murphy et al. · American Journal of Nephrology · 2016 · 130 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa
Blisse Vakkalagadda, Charles Frost, Wonkyung Byon et al. · American Journal of Cardiovascular Drugs · 2016 · 117 citations
Medicine, Pharmacokinetics, Pharmacology +5
1–5 of 15